SOLVENTUM CORP (SOLV)
US83444M1018 - Common Stock
The Second-Best Dow Jones Stock Of 2024 Dives After Earnings Beat
3M stock, Dow Jones Industrial Average component, flirted with a breakout on Tuesday morning after reporting better than expected earnings.
Solventum Stock Earns 81 RS Rating
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.
Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
/PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets...
Solventum Announces Commitment to 100% Renewable Electricity by 2030
/PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today pledges to use 100% renewable electricity across its worldwide operations by 2030. This...
Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer
/PRNewswire/ -- Solventum (NYSE: SOLV) announced today that Dr. Ryan Egeland, MD, has been named chief medical officer. Dr. Egeland is responsible for leading...
Tuesday Sector Laggards: Technology & Communications, Healthcare
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy
/PRNewswire/ -- Solventum (NYSE: SOLV) today announced the launch of the V.A.C.® Peel and Place Dressing, an integrated dressing and drape that can be applied...
3M Stock: Buy, Sell, or Hold?
The uncertainty around 3M's business is starting to clear, but there are still problems here that must be considered.
3M Stock: Buy, Sell, or Hold?
The uncertainty around 3M's business is starting to clear, but there are still problems here that must be considered.
Solventum to Participate in Upcoming Investor Conferences
/PRNewswire/ -- Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences: 2024 Wells Fargo Healthcare Conference in Everett,...
Monday Sector Laggards: Technology & Communications, Healthcare
Pilgrims Pride Larger Than S&P 500 Component Solventum
SOLV Stock Earnings: Solventum Beats EPS, Beats Revenue for Q2 2024
SOLV stock results show that Solventum beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
SOLV Stock Earnings: Solventum Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Solventum (NYSE:SOLV) just reported results for the second quarter of 2024.Solv...
Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance
/PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results as a stand-alone company for the second quarter ended June 30, 2024....
Q3’s Rising Stars: 3 Dow Stocks for Your Must-Watch List
These Dow stocks to watch have all been beaten down over the past year or more but are now poised for a rebound.
3 Reliable Blue-Chips Stocks to Add to Your Summer Buy List
Earn dividends and participate in earnings growth with these blue-chip stocks that beat Q2 earnings and raised guidance.
Wednesday Sector Leaders: Utilities, Healthcare
Why Is Adial Pharmaceuticals (ADIL) Up 61% Today?
Adial Pharmaceuticals stock is up with heavy trading of ADIL after providing investors with an update on its AD04 clinical trial.
SOLV Stock Alert: Solventum Pops as Activist Investor Trian Capital Takes Stake
Solventum stock is up on Tuesday after it was revealed that activist investor Trian Capital has become one of the largest SOLV investors.
Peltz’s Trian Building Stake in 3M Spinoff Solventum
Activist investor Nelson Peltz’s Trian Fund Management has amassed a stake in 3M Co.’s health-care spinoff Solventum Corp.
Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
/PRNewswire/ -- Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday, August 8, 2024 after the U.S. financial markets...
RSI Alert: Solventum (SOLV) Now Oversold
The 3 Most Undervalued Dow Stocks to Buy in July 2024
The venerable index is lagging far behind the performance of the S&P 500, meaning there are undervalued Dow stocks to buy.
U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings
/PRNewswire/ -- Solventum today announced that U.S. News & World Report is expanding its use of Solventum's 3M™ Ambulatory Potentially Preventable...
3 Stocks to Buy Before the Expected Rate Cut Takes Effect
Discover the strategic advantages and growth potential of the top three stocks to buy before interest rate cuts.